Entity

Time filter

Source Type

South San Francisco, CA, United States

Sunesis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of small molecular therapeutics for oncology and other unmet medical needs. The company was founded by Jim Wells,.Founded in 1998, Sunesis filed and completed an IPO in 2005. It is listed on NASDAQ as SNSS. Wikipedia.


Methods of treating, preventing or managing hematologic disorders, such as leukemia are disclosed. The methods encompass the administration of SNS-595. Also provided are methods of treatment using this compound with chemotherapy, radiation therapy, hormonal therapy, biological therapy or immunotherapy. In certain embodiments, the method of treatment comprise administering SNS-595 in combination with Ara-C. Pharmaceutical compositions and single unit dosage forms suitable for use in the methods are also disclosed.


Patent
Sunesis Pharmaceuticals | Date: 2014-08-18

The present invention relates to SNS-595 and methods of treating cancer using the same.


Patent
Biogen Idec and Sunesis Pharmaceuticals | Date: 2014-06-26

The present invention provides compounds useful as inhibitors of Btk, compositions thereof, and methods of using the same.


Patent
Sunesis Pharmaceuticals | Date: 2014-02-03

The present invention relates to SNS-595 and of treating cancer using the same.


Patent
Sunesis Pharmaceuticals | Date: 2014-06-30

Compounds and compositions for treating, preventing or managing cancer are disclosed. The compositions provided herein comprise SNS-595 and N-desmethyl-SNS-595. Also provided are pharmaceutical compositions comprising the compounds and methods of treatment using the compounds and compositions.

Discover hidden collaborations